litlas
Log inCreate account

Steven M. Hersch

Active 1981–2025

74
Papers
17,994
Citations
65
h-index
72
i10-index

Citations

Citations per year for Steven M. Hersch1967: 1 citations1971: 1 citations1982: 1 citations1983: 2 citations1984: 2 citations1985: 4 citations1986: 6 citations1987: 3 citations1988: 2 citations1989: 4 citations1990: 2 citations1991: 5 citations1992: 5 citations1993: 2 citations1994: 10 citations1995: 17 citations1996: 23 citations1997: 47 citations1998: 66 citations1999: 151 citations2000: 199 citations2001: 198 citations2002: 238 citations2003: 288 citations2004: 295 citations2005: 286 citations2006: 294 citations2007: 271 citations2008: 299 citations2009: 289 citations2010: 302 citations2011: 294 citations2012: 234 citations2013: 220 citations2014: 230 citations2015: 155 citations2016: 159 citations2017: 127 citations2018: 114 citations2019: 350 citations2020: 371 citations2021: 306 citations2022: 277 citations2023: 189 citations2024: 322 citations2025: 178 citations2026: 3 citations1968–1970: no citations, so these years are not shown1972–1981: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,532 citing papers, 35.9% of this breakdownUnited Kingdom: 585 citing papers, 8.3% of this breakdownGermany: 400 citing papers, 5.7% of this breakdownCanada: 399 citing papers, 5.7% of this breakdownChina: 353 citing papers, 5% of this breakdownItaly: 298 citing papers, 4.2% of this breakdownFrance: 261 citing papers, 3.7% of this breakdownAustralia: 182 citing papers, 2.6% of this breakdownSwitzerland: 179 citing papers, 2.5% of this breakdownSpain: 170 citing papers, 2.4% of this breakdownJapan: 164 citing papers, 2.3% of this breakdownIndia: 148 citing papers, 2.1% of this breakdown
0%35.9%Other 19.6%

Institutions

Fields

  • Neuroscience52.3%
  • Biochemistry, Genetics and Molecular Biology23.5%
  • Medicine20.3%
  • Nursing1%
  • Psychology0.7%
  • Computer Science0.6%
  • Other1.6%

Topics

  • Genetic Neurodegenerative Diseases14.7%
  • Mitochondrial Function and Pathology10%
  • Neurological disorders and treatments4.9%
  • Neuroscience and Neuropharmacology Research3.4%
  • Muscle Physiology and Disorders2.6%
  • Parkinson's Disease Mechanisms and Treatments2.6%
  • Other61.8%

Coauthors

All papers

Open in search
  1. Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease

    Authors: Lawrence S. Honig, Marwan N. Sabbagh, Christopher H. van Dyck, Reisa A. Sperling, Steven M. Hersch, André Matta, Luigi Giorgi, Michelle Gee, Michio Kanekiyo, David Li, Derk D. Purcell, Shobha Dhadda, Michael C. Irizarry, Lynn D. Kramer - Alzheimer s Research & Therapy 2024 cited by 145

  2. Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer's Disease

    Authors: Sharon Cohen, Christopher H. van Dyck, Michelle Gee, T. Doherty, Michio Kanekiyo, Shobha Dhadda, David K.B. Li, Steven M. Hersch, Michael C. Irizarry, L. D. Kramer - The Journal of Prevention of Alzheimer s Disease 2023 cited by 105

  3. Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine

    Authors: Jianfang Chen, Eileen Marks, Barry Lai, Zhaojie Zhang, James A. Duce, Linh Q. Lam, Irene Volitakis, Ashley I. Bush, Steven M. Hersch, Jonathan H. Fox - PLoS ONE 2013 cited by 174

  4. Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology

    Authors: Claire‐Anne Gutekunst, Shihua Li, Hong Yi, James S. Mulroy, Stefan Kuemmerle, Randi Jones, David B. Rye, Robert J. Ferrante, Steven M. Hersch, Xiaojiang Li - Journal of Neuroscience 1999 cited by 911

  5. Mechanisms of Copper Ion Mediated Huntington's Disease Progression

    Authors: Jonathan H. Fox, Jibrin Kama, Gregory Lieberman, Raman Chopra, Kate Dorsey, Vanita Chopra, Irene Volitakis, Robert A. Cherny, Ashley I. Bush, Steven M. Hersch - PLoS ONE 2007 cited by 213

  6. Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice

    Authors: Robert J. Ferrante, James K. Kubilus, Junghee Lee, Hoon Ryu, Ayshe Ana Beesen, Birgit Zucker, Karen Smith, Neil W. Kowall, Rajiv R. Ratan, Ruth Luthi‐Carter, Steven M. Hersch - Journal of Neuroscience 2003 cited by 689

  7. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion

    Authors: J.-M. Lee, E.M. Ramos, J.-H. Lee, Tammy Gillis, Jayalakshmi Srinidhi Mysore, Michael R. Hayden, Simon C. Warby, PJ Morrison, Martha Nance, Christopher A. Ross, Russell L. Margolis, Ferdinando Squitieri, S. Orobello, Stefano Di Donato, Estrella Gómez‐Tortosa, Carmen Ayuso, Oksana Suchowersky, R J Trent, Elizabeth McCusker, Andrea Novelletto, Marina Frontali, Randi Jones, Tetsuo Ashizawa, Samuel Frank, Marie Saint‐Hilaire, Steven M. Hersch, H. Diana Rosas, Diane Lucente, Madeline Harrison, Andrea Zanko, Ruth K. Abramson, Karen Marder, Jorge Sequeiros, Jane S. Paulsen, G. Bernhard Landwehrmeyer, Richard H. Myers, Marcy E. MacDonald, James F. Gusella, Alexandra Dürr, Adam Rosenblatt, Luigi Frati, Susan B. Perlman, P. M. Conneally, Mary Lou Klimek, Melissa Diggin, Tiffany C. Hadzi, Ayana Duckett, Anwar Ahmed, Paul Allen, David Ames, Christine Anderson, Karla J. Anderson, Karen Anderson, Thomasin Andrews, John Ashburner, Eric Axelson, Elizabeth Aylward, Roger A. Barker, Katrin Barth, Stacey K. Barton, Kathleen Baynes, Alexandra Bea, Erik B. Beall, Mirza Faisal Beg, Leigh J. Beglinger, Kevin Biglan, K. Björk, Steve Blanchard, Jeremy Bockholt, Sudharshan Reddy Bommu, Bradley G. Brossman, Maggie Burrows, Vince D. Calhoun, Noelle E. Carlozzi, Amy M. Chesire, Edmond Chiu, Phyllis Chua, R.J. Connell, Carmela Connor, Jody Corey‐Bloom, David Craufurd, Stephen Cross, Lucette A. Cysique, Rachelle Dar Santos, Jennifer Davis, Joji Decolongon, A. Dipietro, Nicholas Doucette, Nancy R. Downing, Ann Dudler, Steve Dunn, Daniel Ecker, Eric A. Epping, Diane Erickson, Cheryl Erwin, Kenneth Evans, Stewart A. Factor, Sarah Tomaszewski Farias, Marta Fatas, Jess G. Fiedorowicz and 611 more - Neurology 2012 cited by 391

  8. KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients

    Authors: Luisa Quinti, Sharadha Dayalan Naidu, Ulrike Träger, Xiqun Chen, Kimberly B. Kegel-Gleason, David Llères, Colúm Connolly, Vanita Chopra, Cho Low, S. Moniot, Ellen Sapp, Adelaide Tousley, Petr Vodička, Michael J. Van Kanegan, Linda S. Kaltenbach, Lisa A. Crawford, Matthew Fuszard, Maureen Higgins, James R. C. Miller, Ruth Farmer, Vijay Potluri, Susanta Samajdar, Lisa Meisel, Ningzhe Zhang, Andrew R. Snyder, Ross L. Stein, Steven M. Hersch, Lisa Ellerby, Eranthie Weerapana, Michael A. Schwarzschild, Clemens Steegborn, Blair R. Leavitt, Alexei Degterev, Sarah J. Tabrizi, Donald C. Lo, Marian DiFiglia, Leslie M. Thompson, Albena T. Dinkova‐Kostova, Aleksey Kazantsev - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 139

  9. A systems‐level “misunderstanding”: the plasma metabolome in Huntington's disease

    Authors: H. Diana Rosas, Gheorghe Doros, Swati S. Bhasin, Beena Thomas, Sona Gevorkian, Keith Malarick, Wayne R. Matson, Steven M. Hersch - Annals of Clinical and Translational Neurology 2015 cited by 95

  10. The Sirtuin 2 Inhibitor AK-7 Is Neuroprotective in Huntington’s Disease Mouse Models

    Authors: Vanita Chopra, Luisa Quinti, Jinho Kim, Lorraine Vollor, K. Lakshmi Narayanan, Christina K. Edgerly, Patricia M. Cipicchio, Molly A. Lauver, Soo Hyuk Choi, Richard B. Silverman, Robert J. Ferrante, Steven M. Hersch, Aleksey Kazantsev - Cell Reports 2012 cited by 214

  11. Motor, cognitive, and functional declines contribute to a single progressive factor in early HD

    Authors: Scott Schobel, Giuseppe Palermo, Peggy Auinger, Jeffrey D. Long, Shiyang Ma, Omar Khwaja, Dylan Trundell, Merit Cudkowicz, Steven M. Hersch, Cristina Sampaio, E. Ray Dorsey, Blair R. Leavitt, Karl Kieburtz, Jeffrey Sevigny, Douglas R. Langbehn, Sarah J. Tabrizi, For the TRACK-HD, COHORT, CARE-HD, and 2CARE Huntington Study Group Investigators, TRACK-HD, COHORT, CARE-HD, and 2CARE Huntington Study Group Investigators, John Adams, Mandar Jog, Christopher Hyson, Sarah Furtado, Andrew P. Duker, Melissa J. Armstrong, Christian Lachner, Hubert H. Fernandez, Michael S. Okun, David Shprecher, Michael S. Cartwright, Clement T. Loy, Joohi Jiminez-Shahed, B. Robottom, Gregory Suter, Theresa HM Moore, Jane Forsyth, Andrea Hurt, Joann Belden, Katie Price, Diane Erickson, Breanna Nickels, Misty M. Thompson, Linda Cole, Julie Megens, Emilija Makaji, Sara-Lynn Masse, Keith Malarick, Louisa Mook, Susan Maya, Alex Bender, Jessica Meyer, Puja Turakhia, Katherine Harwood, Kathryn Duderstadt, S. Lenarz, Judy Hamerlinck, Patricia Edern, Charlyne Hickey, Ashley Owens, Clare Gibbons, Carolyn Steele Gray, Jean A. Jaglin, Kimberly Janko, Holly Lawrence, B. Estes, Brigid Hayward, Allison E. Johnson, Amit Gode, Giselle Huet, Beverly Romero-Kersh, K. Wernette, Elizabeth Sullivan, Jamie Guyot, Julie Konkle, Christine J. O’Neill, Pamela King, Amanda Martin, John Bautista, Nicole Mans, Jane Griffith, Erica Surles, Sharon Halton, Alicia Palao, Nathalie Padron, Kolleen Elliott, Lynn Elizabeth Oelke, London Butterfield, Peggy Perry-Trice, Sarah Wyne, Carol Pantella, Lorelei Tainsh, Elaine Sperin, Sharon Evans, Maureen Gartner, Amy Duffy, Pamela Kristof, Lisa Niles, Steven Rainone, Angie Wernle, Ronda Clouse, Michelle Cines and 302 more - Neurology 2017 cited by 155

  12. The CREST-E study of creatine for Huntington disease

    Authors: Steven M. Hersch, Giovanni Schifitto, David Oakes, Amy‐Lee Bredlau, Catherine M. Meyers, Richard L. Nahin, H. Diana Rosas, For the Huntington Study Group CREST-E Investigators and Coordinators - Neurology 2017 cited by 93

  13. Regional and progressive thinning of the cortical ribbon in Huntington’s disease

    Authors: H. Diana Rosas, A. K. Liu, Steven M. Hersch, Maureen Glessner, Robert J. Ferrante, David H. Salat, André van der Kouwe, Bruce G. Jenkins, Anders M. Dale, Bruce Fischl - Neurology 2002 cited by 1,048

  14. Fragile X Mental Retardation Protein: Nucleocytoplasmic Shuttling and Association with Somatodendritic Ribosomes

    Authors: Yue Feng, Claire‐Anne Gutekunst, Derek E. Eberhart, Hong Yi, Stephen T. Warren, Steven M. Hersch - Journal of Neuroscience 1997 cited by 535

  15. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity

    Authors: H. Diana Rosas, David H. Salat, Shing Yip Lee, Alexandra K. Zaleta, Vasanth Pappu, Bruce Fischl, Douglas N. Greve, Nathanael D. Hevelone, Steven M. Hersch - Brain 2008 cited by 492

  16. Altered white matter microstructure in the corpus callosum in Huntington's disease: Implications for cortical "disconnection"

    Authors: H. Diana Rosas, Stephanie Y. Lee, Alexander C. Bender, Alexandra K. Zaleta, Mark G. Vangel, Peng Yu, Bruce Fischl, Vasanth Pappu, Christina E. Onorato, Jang-Ho Cha, David H. Salat, Steven M. Hersch - NeuroImage 2009 cited by 280

  17. Alterations in Brain Transition Metals in Huntington Disease

    Authors: H. Diana Rosas, Yawen Chen, Gheorghe Doros, David H. Salat, Nan‐kuei Chen, Kenneth K. Kwong, Ashley I. Bush, Jonathan H. Fox, Steven M. Hersch - Archives of Neurology 2012 cited by 158

  18. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures

    Authors: H. Diana Rosas, David S. Tuch, Nathanael D. Hevelone, Alexandra K. Zaleta, Márk Vangel, Steven M. Hersch, David H. Salat - Movement Disorders 2006 cited by 339

  19. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies.

    Authors: Allan I. Levey, Steven M. Hersch, David B. Rye, Roger K. Sunahara, Hyman B. Niznik, C. A. Kitt, Donald L. Price, Roberto Maggio, Mark R. Brann, B.J. Ciliax - National Academy of Sciences, Proceedings of the National Academy of Sciences 1993 cited by 624

  20. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease

    Authors: Fran Borovečki, Luca Lovrečić, Jingan Zhou, Hyeong-Chai Jeong, Florian Then, H. Diana Rosas, Steven M. Hersch, Penelope Hogarth, Bérengère Bouzou, Roderick V. Jensen, Dimitri Krainc - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 441

  21. Association of Dilated Perivascular Spaces and Disease Severity in Patients With Huntington Disease

    Authors: Suk‐Tak Chan, Nathaniel D. Mercaldo, Bernard Ravina, Steven M. Hersch, H. Diana Rosas - Neurology 2020 cited by 39

  22. Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease

    Authors: Anthone W. Dunah, Hyunkyung Jeong, April M. Griffin, Yong‐Man Kim, David G. Standaert, Steven M. Hersch, M. Maral Mouradian, Anne B. Young, Naoko Tanese, Dimitri Krainc - Science 2002 cited by 708

  23. Caspase Cleavage of Mutant Huntingtin Precedes Neurodegeneration in Huntington's Disease

    Authors: Cheryl L. Wellington, Lisa Ellerby, Claire‐Anne Gutekunst, Danny H. Rogers, Simon C. Warby, Rona K. Graham, Odell Loubser, Jeremy M. Van Raamsdonk, Roshni R. Singaraja, Yuzhou Yang, Juliette Gafni, Dale E. Bredesen, Steven M. Hersch, Blair R. Leavitt, Sophie Roy, Donald W. Nicholson, Michael R. Hayden - Journal of Neuroscience 2002 cited by 402

  24. Therapeutic Effects of Coenzyme Q10and Remacemide in Transgenic Mouse Models of Huntington's Disease

    Authors: Robert J. Ferrante, Ole A. Andreassen, Alpaslan Dedeoglu, Kimberly L. Ferrante, Bruce G. Jenkins, Steven M. Hersch, M. Flint Beal - Journal of Neuroscience 2002 cited by 392